Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
1.147
-0.013 (-1.16%)
Nov 11, 2025, 2:07 PM EST - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Cancer Therapeutics
1.89M
Log In
Log In
Cancer Therapeutics Growth
-90.55%
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
United States
1.89M
Log In
Log In
United States Growth
-90.55%
Log In
Log In